Works Cited

1. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Available at https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Last accessed May 1, 2022.

2. Cornell S, Halstenson C, Miller DK (eds). The Art and Science of Diabetes Self-Management Education: Desk Reference. 5th ed. Chicago, IL: American Association of Diabetes Educators; 2020.

3. International Diabetes Federation. What Is Diabetes? Available at https://www.idf.org/aboutdiabetes/what-is-diabetes. Last accessed May 17, 2022.

4. Diabetes Pro. Fast Facts: Data and Statistics About Diabetes. Available at https://professional.diabetes.org/content/fast-facts-data-and-statistics-about-diabetes. Last accessed May 10, 2022.

5. Saeedi P, Petersohn I, Salpea P, et al. Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. 9th ed. Amsterdam, Netherlands: Diabetes Research and Clinical Practice; 2019.

6. Centers for Disease Control and Prevention. Diagnosed Diabetes. Available at https://gis.cdc.gov/grasp/diabetes/DiabetesAtlas.html. Last accessed May 10, 2022.

7. Kissela BM, Khoury J, Kleindorfer D, et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/northern Kentucky stroke study. Diabetes Care. 2005;28(2):355-359.

8. Centers for Disease Control and Prevention. Prevalence of Cardiovascular Disease: Stroke. Available at https://gis.cdc.gov/grasp/diabetes/DiabetesAtlas.html. Last accessed May 10, 2022.

9. American Diabetes Association. Standards of medical care in diabetes—2022. Diabetes Care. 2022;41(Suppl 1):S17-S38.

10. Childs BP, Cypress M, Spollett G (eds). Complete Nurse's Guide to Diabetes Care. 3rd ed. Alexandria, VA: American Diabetes Association; 2017.

11. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2016;39(Suppl 1):S1-S106.

12. Westerfield J, Holcomb S, Jensen S (eds). Current Trends in Diabetes Management: A Guide for the Healthcare Professional. 7th ed. Nashville, TN: Healthways; 2008.

13. Southerland JH, Taylor GW, Offenbacher S. Diabetes and periodontal infection: making the connection. Diabetes Care. 2005;23(4):171-178.

14. Madhu SV. Endothelial dysfunction and diabetes. JAPI. 2010;58:475-476.

15. Lorber D. Macrovascular disease in diabetes. In: Mensing C (ed). The Art and Science of Diabetes Self-Management Education: A Desk Reference for Healthcare Professionals. Chicago, IL: American Association of Diabetes Educators; 2006:475-510.

16. Air EL, Kissela BM. Diabetes, the metabolic syndrome, and ischemic stroke: epidemiology and possible mechanisms. Diabetes Care. 2007;30(12):3131-3140.

17. Boss BJ, Huether SE. Alterations in cognitive systems, cerebral hemodynamics, and motor function. In: Huether SE, McCance KL, Brashers VL (eds). Understanding Pathophysiology. 7th ed. St. Louis, MO: Mosby; 2020: 351-383.

18. Centers for Disease Control and Prevention. Stroke Facts. Available at https://www.cdc.gov/stroke/facts.htm. Last accessed May 11, 2022.

19. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2(1):43-53.

20. Hyvärinen M, Tuomilehto J, Mähönen M, et al. Hyperglycemia and incidence of ischemic and hemorrhagic stroke: comparison between fasting and 2-hour glucose criteria. Stroke. 2009;40(5):1633-1637.

21. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke. 1999;30(12):2513-2516.

22. Grau AJ, Weimar C, Buggle F, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German Stroke Data Bank. Stroke. 2001;32(11):2559-2566.

23. Frishman W, Ismail A. Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target? Cardiol Rev. 2002;10(4):199-210.

24. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418.

25. Donnan G, Norrving B, Bamford J, Bogousslavsky J. Classification of subcortical infarcts. In: Donnan G, Norrving B, Bamford J, Bogousslavsky J (eds). Subcortical Stroke. 2nd ed. Oxford: Oxford Medical Publications; 2002: 27-34.

26. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6(7):611-619.

27. Bokura H, Kobayashi S, Yamaguchi S, et al. Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J Stroke Cerebrovasc Dis. 2006;15(2):57-63.

28. Tuttolomondo A, Pinto A, Salemi G, et al. Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome. Nutr Metab Cardiovasc Dis. 2008;18(2):152-157.

29. Olsen TS. Regional cerebral blood flow after occlusion of the middle cerebral artery. Acta Neurol Scand. 1986;73(4):321-337.

30. Davis FA (ed). Taber's Cyclopedic Medical Dictionary. 24th ed. Philadelphia, PA: FA Davis Company; 2021.

31. Jauch EC. Ischemic Stroke Treatment and Management: Mechanical Thrombectomy. Available at https://emedicine.medscape.com/article/1916852-treatment. Last accessed May 12, 2022.

32. National Institute of Neurological Disorders and Stroke. Transient Ischemic Attack Information Page. Available at https://www.ninds.nih.gov/Disorders/All-Disorders/Transient-Ischemic-Attack-Information-Page. Last accessed May 12, 2022.

33. Hewko C. Acute ischemic stroke: swift assessment and quick action produce optimal outcomes. JAAPA. 2004;17(7):19-25.

34. Savitz SI, Caplan LR. Vertebrobasilar disease. N Engl J Med. 2005;352(25):2618-2626.

35. Williams O, Leighton-Hermann E, DeSorbo A, et al. Hip Hop Stroke: study protocol for a randomized controlled trial to address stroke literacy. J Clin Trials. 2015;5(5):pii:242.

36. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317-1329.

37. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40(8):2945-2948.

38. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase 3–4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008;372(9646):1303-1309.

39. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384(9958):1929-1935.

40. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28(11):2109-2118.

41. Diedler J, Ahmed N, Sykora M, et al. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Stroke. 2010;(2):288-294.

42. Xian Y, Federspiel JJ, Grau-Sepulveda M, et al. Risks and benefits associated with prestroke antiplatelet therapy among patients with acute ischemic stroke treated with intravenous tissue plasminogen activator. JAMA Neurol. 2016;73(1):50-59.

43. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-1587.

44. Kwiatkowski TG, Libman RB, Frankel M, et al. for the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med. 1999;340(23):1781-1787.

45. Lyden PD. Thrombolytic Therapy for Acute Stroke. 3rd ed. Totowa, NJ: Humana Press; 2015.

46. National Stroke Association. Stroke Treatments. Available at https://www.stroke.org/en/about-stroke/treatment. Last accessed May 16, 2022.

47. Lutsep HL. Mechanical Thrombolysis in Acute Stroke. Available at https://emedicine.medscape.com/article/1163240-overview. Last accessed May 16, 2022.

48. Powers WJ, Derdeyn CP, Biller J, et al. 2015 AHA/ASA focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(10):3020-3035.

49. Hassan AE, Aman MM, Chauhdry SA, et al. Value of other endovascular techniques among patients with MERCI device failure during the treatment of acute ischemic stroke: what to do when MERCI fails? J Vasc Interv Neurol. 2013;5(2):27-31.

50. Jeffrey S. Solitaire Device for Stroke Gets FDA Nod. Available at https://www.medscape.com/viewarticle/759773. Last accessed May 16, 2022.

51. Stryker.com. Stryker's Trevo Retriever Becomes First and Only Device Indicated for Treatment Up to 24 Hours, Aligning with New AHA/ASA Guidelines. Available at https://www.stryker.com/us/en/about/news/2018/stryker_s-trevo--retriever-becomes-first-and-only-device-indicat.html. Last accessed May 16, 2022.

52. Chinese Acute Stroke Trial (CAST) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997;349(9066):1641-1649.

53. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997;349(9065):1569-1581.

54. Sandercock PA, Counsell C, Tseng MC, Cecconi E. Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014;3:CD000029.

55. Lapchak PA, Araujo DM. Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in the management of ischemic stroke. Am J Cardiovasc Drugs. 2003;3(2):87-94.

56. Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke. 2005;36(4):880-890.

57. Kleindorfer DO, Towfighi A, Chaturvedi S. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364-e467.

58. Williams O, Leighton-Herrmann Quinn E, Teresi J, et al. Improving community stroke preparedness in the HHS (Hip-Hop Stroke) randomized clinical trial. Stroke. 2018;49(4):972-979.

59. Bloomgarden ZT. Inpatient diabetes control: approaches to treatment. Diabetes Care. 2004;27(9):2272-2277.

60. Müller-Nordhorn J, Nolte CH, Rossnagel K, et al. Knowledge about risk factors for stroke: a population-based survey with 28,090 participants. Stroke. 2006;37(4):946-950.

61. Schneider AT, Pancioli AM, Khoury JC, et al. Trends in community knowledge of the warning signs and risk factors for stroke. JAMA. 2003;289(3):343-346.

62. Miller-Hoover S. Stroke Awareness: Act F.A.S.T. Available at https://www.rn.com/nursing-news/stroke-awareness-act-fast. Last accessed May 16, 2022.

63. Rosamond WD, Gorton RA, Hinn AR, Hohenhaus SM, Morris DL. Rapid response to stroke symptoms: the Delay in Accessing Stroke Healthcare (DASH) study. Acad Emerg Med. 1998;5(1):45-51.

64. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997;349(9065):1569-1581.

65. California Acute Stroke Pilot Registry (CASPR) Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology. 2005;64(4):654-659.

66. Wattigney WA, Croft JB, Mensah GA, et al. Establishing data elements for the Paul Coverdell National Acute Stroke Registry. Part 1: proceedings of an expert panel. Stroke. 2003;34(1):151-156.

67. Kothari R, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med. 1999;33(4):373-378.

68. Kleindorfer D, Miller R, Moomaw CJ, et al. Designing a message for public education regarding stroke: does FAST capture enough stroke? Stroke. 2007;38(10):2864-2868.

69. ElSayed NA, Aleppo G, Aroda VR, et al. Prevention or delay of type 2 diabetes and associated comorbidities: Standards of Care in Diabetes—2023. Diabetes Care. 2023;46(Supplement_1):S41-S48.

Evidence-Based Practice Recommendations Citations

1. American Diabetes Association Professional Practice Committee. Classification and diagnosis of diabetes: standards of medical care in diabetes—2022. Diabetes Care. 2021;45(Suppl 1):S17-S38. Available at https://diabetesjournals.org/care/issue/45/Supplement_1. Last accessed May 20, 2022.


Copyright © 2022 NetCE, PO Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.